Vident Investment Advisory’s CyrusOne Inc Common Stock CONE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-20,338
Closed -$1.82M 1361
2021
Q4
$1.82M Buy
20,338
+2,320
+13% +$197K 0.05% 492
2021
Q3
$1.4M Buy
18,018
+2,266
+14% +$170K 0.04% 572
2021
Q2
$1.13M Sell
15,752
-481
-3% -$35K 0.03% 627
2021
Q1
$1.1M Buy
16,233
+3,677
+29% +$255K 0.04% 589
2020
Q4
$919K Buy
12,556
+950
+8% +$68.9K 0.04% 562
2020
Q3
$813K Sell
11,606
-4,711
-29% -$369K 0.04% 549
2020
Q2
$1.19M Sell
16,317
-1,653
-9% -$118K 0.06% 424
2020
Q1
$1.11M Buy
17,970
+209
+1% +$12.8K 0.07% 359
2019
Q4
$1.16M Buy
+17,761
New +$1.22M 0.07% 383
2019
Q2
Sell
-18,415
Closed -$966K 675
2019
Q1
$966K Buy
18,415
+4,391
+31% +$230K 0.05% 421
2018
Q4
$742K Buy
14,024
+2,281
+19% +$130K 0.04% 492
2018
Q3
$745K Buy
11,743
+2,969
+34% +$192K 0.03% 560
2018
Q2
$512K Buy
+8,774
New +$476K 0.02% 647

Other funds holding CONE

Vident Investment Advisory's CONE Position: Q1 2022 in Review

Vident Investment Advisory sold out of CyrusOne Inc Common Stock (CONE) in Q1 2022, closing a stake of 20,338 shares — an estimated $1.82M sold.

Vident Investment Advisory first reported a position in CONE in Q2 2018 and held it in 13 quarters. The position peaked at $1.82M in Q4 2021. 3 funds tracked by Wall St. Rank hold CONE as of Q1 2022.

  • Vident Investment Advisory reported no remaining CyrusOne Inc Common Stock position as of Q1 2022 after selling out during the quarter.
  • Vident Investment Advisory sold 20,338 CyrusOne Inc Common Stock shares in Q1 2022, an estimated $1.82M.
  • Vident Investment Advisory first reported a position in CyrusOne Inc Common Stock in Q2 2018 and held it in 13 quarters.
  • Vident Investment Advisory's CyrusOne Inc Common Stock position peaked at $1.82M in Q4 2021.
  • 3 funds tracked by Wall St. Rank held CyrusOne Inc Common Stock as of Q1 2022.

Based on Vident Investment Advisory's 13F filing for Q1 2022, filed 16 May 2022.